Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.87
+0.57 (6.87%)
At close: Apr 28, 2026, 4:00 PM EDT
8.90
+0.03 (0.34%)
After-hours: Apr 28, 2026, 5:34 PM EDT

ARCT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
82.03152.31166.820612.36
Revenue Growth (YoY)
-46.14%-8.69%-19.03%1566.79%29.56%
Gross Profit
82.03152.31166.820612.36
Selling, General & Admin
46.0852.8252.8746.0741.45
Research & Development
112.21195.16192.13147.75173.76
Total Operating Expenses
158.29247.98245193.82215.21
Operating Income
-76.26-95.67-78.2112.18-202.85
Total Non-Operating Income (Expense)
10.4814.7250.32-1.53-0.82
Pretax Income
-65.78-80.95-27.8910.64-203.67
Provision for Income Taxes
--01.841.3-
Net Income
-65.78-80.94-29.739.35-203.67
Net Income to Common
-65.78-80.94-29.739.35-203.67
Shares Outstanding (Basic)
2827272726
Shares Outstanding (Diluted)
2827272726
Shares Change (YoY)
4.86%1.00%1.03%0.69%0.69%
EPS (Basic)
-2.32-2.99-1.110.35-7.72
EPS (Diluted)
-2.32-2.99-1.110.35-7.72
Shares Outstanding
28.4127.126.8326.5626.37
Free Cash Flow
-74.5-60.4-2124.27-138.45
Free Cash Flow Per Share
-2.62-2.23-0.780.91-5.25
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-92.96%-62.81%-46.89%5.91%-1641.33%
Profit Margin
-80.19%-53.14%-17.82%4.54%-1647.98%
FCF Margin
-90.82%-39.65%-12.59%11.78%-1120.23%
EBITDA
-73.24-92.13-75.2513.7-201.66
EBITDA Margin
-89.28%-60.49%-45.11%6.65%-1631.68%
EBIT
-76.26-95.67-78.2112.18-202.85
EBIT Margin
-92.96%-62.81%-46.89%5.91%-1641.33%
Effective Tax Rate
0.00%0.00%-6.58%12.17%0.00%
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q